Siemens Fonds Invest GmbH increased its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 436.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,780 shares of the company's stock after purchasing an additional 19,347 shares during the period. Siemens Fonds Invest GmbH's holdings in Corteva were worth $1,355,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the business. Chicago Partners Investment Group LLC lifted its position in Corteva by 1.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 13,282 shares of the company's stock valued at $759,000 after acquiring an additional 156 shares in the last quarter. Avidian Wealth Enterprises LLC increased its stake in Corteva by 3.6% in the 4th quarter. Avidian Wealth Enterprises LLC now owns 4,521 shares of the company's stock valued at $258,000 after buying an additional 157 shares during the last quarter. Beacon Capital Management LLC increased its stake in Corteva by 13.4% in the 4th quarter. Beacon Capital Management LLC now owns 1,341 shares of the company's stock valued at $76,000 after buying an additional 158 shares during the last quarter. Lake Street Advisors Group LLC increased its stake in Corteva by 3.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 4,514 shares of the company's stock valued at $257,000 after buying an additional 160 shares during the last quarter. Finally, Sepio Capital LP increased its stake in Corteva by 3.2% in the 4th quarter. Sepio Capital LP now owns 5,361 shares of the company's stock valued at $305,000 after buying an additional 166 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.
Corteva Stock Performance
CTVA traded up $0.13 on Monday, reaching $70.93. The company had a trading volume of 3,578,426 shares, compared to its average volume of 3,309,713. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $71.11. The stock has a market cap of $48.39 billion, a P/E ratio of 54.98, a P/E/G ratio of 1.68 and a beta of 0.72. The company's fifty day moving average is $63.46 and its 200 day moving average is $61.80. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $1.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.88 by $0.25. The firm had revenue of $4.42 billion during the quarter, compared to the consensus estimate of $4.56 billion. Corteva had a net margin of 5.36% and a return on equity of 7.19%. The business's revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.89 EPS. As a group, analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date of this dividend is Monday, June 2nd. Corteva's dividend payout ratio (DPR) is presently 41.46%.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. Morgan Stanley lifted their price target on shares of Corteva from $65.00 to $71.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Royal Bank of Canada boosted their price objective on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research note on Friday, February 7th. Wells Fargo & Company boosted their price objective on shares of Corteva from $73.00 to $79.00 and gave the stock an "overweight" rating in a research note on Monday, May 12th. KeyCorp boosted their price objective on shares of Corteva from $71.00 to $72.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Finally, Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price objective on the stock in a research note on Monday, March 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $70.50.
Get Our Latest Report on Corteva
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.